Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enamel Matrix Proteins in Periodontal Maintenance
NCT02972788Phase 1Completed
- Sponsor
- University of Nebraska
- Start
- Feb 2017
- Primary completion
- Sep 2018
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of enamel matrix derivative in chronic periodontitis (2 arms), sponsored by University of Nebraska. Primary endpoint: Clinical Attachment Levels at 12 months. Started Feb 2017; status: completed.
02
Drugs
enamel matrix derivative
03
Conditions
chronic periodontitis
Beyond the preview
Go deeper on NCT02972788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02972788.